• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

20年间胆囊癌确诊患者的预后因素:一项队列研究

Prognostic Factors in Patients Diagnosed with Gallbladder Cancer over a Period of 20 Years: A Cohort Study.

作者信息

Toussi Nima, Daida Krishna, Moser Michael, Le Duc, Hagel Kimberly, Kanthan Rani, Shaw John, Zaidi Adnan, Chalchal Haji, Ahmed Shahid

机构信息

College of Medicine, University of Saskatchewan, Saskatoon, SK S7N4H4, Canada.

Department of Surgery, University of Saskatchewan, Saskatoon, SK S7N0W8, Canada.

出版信息

Cancers (Basel). 2024 Aug 23;16(17):2932. doi: 10.3390/cancers16172932.

DOI:10.3390/cancers16172932
PMID:39272789
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11394600/
Abstract

BACKGROUND

Gallbladder cancer (GBC) is an uncommon cancer. This study aimed to determine the outcomes of GBC in relation to geographic, demographic, and clinical factors in a Canadian province from 2000 to 2019.

METHODS

This population-based retrospective cohort study included all patients diagnosed with gallbladder cancer (GBC) in Saskatchewan, Canada, from 2000 to 2019. Cox proportional multivariate regression analysis was conducted to identify factors associated with poorer outcomes.

RESULTS

In total, 331 patients with a median age of 74 years and male-female ratio of 1:2 were identified. Of these patients, 305 (92%) had a pathological diagnosis of GBC. Among patients with documented staging data, 64% had stage IV disease. A total of 217 (66%) patients were rural residents, and 149 (45%) were referred to a cancer center. The multivariate analysis for patients with stage I-III GBC showed that stage III disease [hazard ratio (HR), 2.63; 95% confidence interval (CI), 1.09-6.34)] and urban residence (HR, 2.20; 95% CI, 1.1-4.39) were correlated with inferior disease-free survival. For all patients, stage IV disease (HR, 3.02; 95% CI, 1.85-4.94), no referral to a cancer center (HR, 2.64; 95% CI, 1.51-4.62), lack of surgery (HR, 1.63; 95% CI, 1.03-2.57), a neutrophil-lymphocyte ratio of >3.2 (HR, 1.57; 1.05-2.36), and age of ≥70 years (HR, 1.51; 95% CI, 1.04-2.19) were correlated with inferior overall survival.

CONCLUSIONS

In this real-world context, the majority of patients with GBC were diagnosed at a late stage and were not referred to a cancer center. For those with early-stage GBC, living in an urban area and having stage III disease were linked to worse outcomes. Across all stages of GBC, stage IV disease, older age, absence of surgery, lack of referral to a cancer center, and a high neutrophil-to-lymphocyte ratio were associated with poorer survival.

摘要

背景

胆囊癌(GBC)是一种罕见的癌症。本研究旨在确定2000年至2019年加拿大一个省份胆囊癌患者的预后与地理、人口统计学和临床因素之间的关系。

方法

这项基于人群的回顾性队列研究纳入了2000年至2019年在加拿大萨斯喀彻温省被诊断为胆囊癌(GBC)的所有患者。进行了Cox比例多变量回归分析,以确定与较差预后相关的因素。

结果

总共确定了331例患者,中位年龄为74岁,男女比例为1:2。在这些患者中,305例(92%)有胆囊癌的病理诊断。在有记录分期数据的患者中,64%患有IV期疾病。共有217例(66%)患者为农村居民,149例(45%)被转诊至癌症中心。对I-III期胆囊癌患者的多变量分析显示,III期疾病[风险比(HR),2.63;95%置信区间(CI),1.09-6.34]和城市居住(HR,2.20;95%CI,1.1-4.39)与无病生存期较差相关。对于所有患者,IV期疾病(HR,3.02;95%CI,1.85-4.94)、未转诊至癌症中心(HR,2.64;95%CI,1.51-4.62)、未进行手术(HR,1.63;95%CI,1.03-2.57)、中性粒细胞与淋巴细胞比值>3.2(HR,1.57;1.05-2.36)以及年龄≥70岁(HR,1.51;95%CI,1.04-2.19)与总生存期较差相关。

结论

在这个现实世界的背景下,大多数胆囊癌患者在晚期被诊断出来,并且没有被转诊至癌症中心。对于早期胆囊癌患者,居住在城市地区和患有III期疾病与较差的预后相关。在胆囊癌的所有阶段,IV期疾病、年龄较大、未进行手术、未转诊至癌症中心以及高中性粒细胞与淋巴细胞比值与较差的生存率相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6913/11394600/a46639b1c5ac/cancers-16-02932-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6913/11394600/a07c0fc0f431/cancers-16-02932-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6913/11394600/a46639b1c5ac/cancers-16-02932-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6913/11394600/a07c0fc0f431/cancers-16-02932-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6913/11394600/a46639b1c5ac/cancers-16-02932-g002.jpg

相似文献

1
Prognostic Factors in Patients Diagnosed with Gallbladder Cancer over a Period of 20 Years: A Cohort Study.20年间胆囊癌确诊患者的预后因素:一项队列研究
Cancers (Basel). 2024 Aug 23;16(17):2932. doi: 10.3390/cancers16172932.
2
Prognostic significance of neutrophil to lymphocyte ratio in patients with gallbladder carcinoma.中性粒细胞与淋巴细胞比值在胆囊癌患者中的预后意义。
HPB (Oxford). 2016 Jul;18(7):600-7. doi: 10.1016/j.hpb.2016.03.608. Epub 2016 May 6.
3
Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin.吉西他滨联合顺铂治疗不可切除的胆囊癌的疗效和预后因素。
BMC Cancer. 2019 Jan 5;19(1):10. doi: 10.1186/s12885-018-5211-y.
4
Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC).胆囊癌(GBC):纪念斯隆凯特琳癌症中心(MSKCC)的10年经验。
J Surg Oncol. 2008 Dec 1;98(7):485-9. doi: 10.1002/jso.21141.
5
Outcomes of Rural Men with Breast Cancer: A Multicenter Population Based Retrospective Cohort Study.农村男性乳腺癌患者的结局:一项基于多中心人群的回顾性队列研究。
Cancers (Basel). 2023 Mar 27;15(7):1995. doi: 10.3390/cancers15071995.
6
The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.手术及辅助治疗在胆囊和肝内胆管淋巴结阳性癌症中的作用。
Cancer. 2018 Jan 1;124(1):74-83. doi: 10.1002/cncr.30968. Epub 2017 Aug 25.
7
Survival analysis and prognostic factors of the carcinoma of gallbladder.胆囊癌的生存分析及预后因素。
World J Surg Oncol. 2022 Dec 20;20(1):403. doi: 10.1186/s12957-022-02857-y.
8
Surgical Resection of Primary Tumor in Asymptomatic or Minimally Symptomatic Patients With Stage IV Colorectal Cancer: A Canadian Province Experience.对无症状或症状轻微的IV期结直肠癌患者进行原发性肿瘤的手术切除:加拿大一个省的经验。
Clin Colorectal Cancer. 2015 Dec;14(4):e41-7. doi: 10.1016/j.clcc.2015.05.008. Epub 2015 Jun 6.
9
Characteristics and outcomes of gallbladder cancer patients at the Tata Medical Center, Kolkata 2017-2019.2017-2019 年加尔各答塔塔医疗中心胆囊癌患者的特征和结局。
Cancer Med. 2023 Apr;12(8):9293-9302. doi: 10.1002/cam4.5677. Epub 2023 Feb 13.
10
Prognostic significance of neutrophil-lymphocyte ratio and carbohydrate antigen 19-9 in patients with gallbladder carcinoma.中性粒细胞与淋巴细胞比值及糖类抗原19-9在胆囊癌患者中的预后意义
Medicine (Baltimore). 2019 Feb;98(8):e14550. doi: 10.1097/MD.0000000000014550.

本文引用的文献

1
Survival benefit of adjuvant chemotherapy in patients with resected gallbladder adenocarcinoma: An updated retrospective cohort analysis.胆囊腺癌患者术后辅助化疗的生存获益:一项更新的回顾性队列分析。
Eur J Surg Oncol. 2024 Apr;50(4):108047. doi: 10.1016/j.ejso.2024.108047. Epub 2024 Feb 21.
2
Role of chemoradiation in gallbladder cancer-a single institution retrospective analysis.放化疗在胆囊癌中的作用——单机构回顾性分析
J Gastrointest Oncol. 2023 Oct 31;14(5):2212-2220. doi: 10.21037/jgo-23-186. Epub 2023 Oct 17.
3
Equitable Access to Clinical Trials: How Do We Achieve It?
公平获得临床试验的机会:我们如何实现?
Am Soc Clin Oncol Educ Book. 2023 May;43:e389838. doi: 10.1200/EDBK_389838.
4
Harnessing Real-World Evidence to Advance Cancer Research.利用真实世界证据推进癌症研究。
Curr Oncol. 2023 Feb 2;30(2):1844-1859. doi: 10.3390/curroncol30020143.
5
Characteristics and outcomes of gallbladder cancer patients at the Tata Medical Center, Kolkata 2017-2019.2017-2019 年加尔各答塔塔医疗中心胆囊癌患者的特征和结局。
Cancer Med. 2023 Apr;12(8):9293-9302. doi: 10.1002/cam4.5677. Epub 2023 Feb 13.
6
Survival analysis and prognostic factors of the carcinoma of gallbladder.胆囊癌的生存分析及预后因素。
World J Surg Oncol. 2022 Dec 20;20(1):403. doi: 10.1186/s12957-022-02857-y.
7
Stage IV non-small cell lung cancer among young individuals: Incidence, presentations, and survival outcomes of conventional therapies.年轻个体中的IV期非小细胞肺癌:传统疗法的发病率、临床表现及生存结果
Front Oncol. 2022 Nov 11;12:894780. doi: 10.3389/fonc.2022.894780. eCollection 2022.
8
Understanding the mechanisms of gallbladder lesions: A systematic review.了解胆囊病变的机制:一项系统综述。
Exp Ther Med. 2022 Jul 29;24(3):604. doi: 10.3892/etm.2022.11541. eCollection 2022 Sep.
9
Where Have We Been With Rural-Urban Cancer Care Disparities and Where Are We Headed?城乡癌症护理差异:我们走过了哪些历程,又将走向何方?
JAMA Netw Open. 2022 May 2;5(5):e2212255. doi: 10.1001/jamanetworkopen.2022.12255.
10
Racial and Ethnic Differences in Rural-Urban Trends in 5-Year Survival of Patients With Lung, Prostate, Breast, and Colorectal Cancers: 1975-2011 Surveillance, Epidemiology, and End Results (SEER).农村-城市地区肺癌、前列腺癌、乳腺癌和结直肠癌患者 5 年生存率的城乡趋势的种族和民族差异:1975-2011 年监测、流行病学和最终结果(SEER)。
JAMA Netw Open. 2022 May 2;5(5):e2212246. doi: 10.1001/jamanetworkopen.2022.12246.